Literature DB >> 18622411

Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival.

J A Lopes1, S Gonçalves, S Jorge, M Raimundo, L Resende, F Lourenço, J F Lacerda, C Martins, J A do Carmo, J M F Lacerda, M M Prata.   

Abstract

We evaluated retrospectively the incidence of acute kidney injury (AKI), defined by risk, injury, failure, loss and end-stage kidney disease (RIFLE) and its influence on long-term survival, in 82 patients aged 18-60 years who underwent a reduced intensity conditioning (RIC) haematopoietic cell transplantation (HCT). Patients (53.6%) developed AKI after HCT: 25% were on risk, 45.5% on injury and 29.5% on failure. In all, 64 patients survived after 100 days of post transplant and were available for long-term survival analysis. At follow-up, 43.7% of patients died. A 5-year overall survival of AKI patients was 41.6% as compared with 67.1% for those who did not develop AKI (P=0.028), and decreased according to AKI severity (risk, 55.6%; injury plus failure, 33.3%; P=0.045). After adjusting for age, history of cardiovascular disease, high-risk disease and chronic GVHD, AKI predicted 5-year overall mortality (AKI: adjusted hazards ratio (AHR), 2.36, 95% CI: 1.03-5.37; P=0.041). Moreover, moderate and severe AKI (injury plus failure) was also associated with an increased 5-year overall mortality (injury plus failure: AHR, 1.64, 95% CI: 1.06-2.54; P=0.024). According to RIFLE, 53.6% of patients had AKI after RIC HCT. Such patients have poor long-term survival, particularly in moderate or severe AKI.

Entities:  

Mesh:

Year:  2008        PMID: 18622411     DOI: 10.1038/bmt.2008.207

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

Review 1.  Acute kidney injury in hematopoietic cell transplantation.

Authors:  Amy Kogon; Sangeeta Hingorani
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

Review 2.  Acute kidney injury in HCT: an update.

Authors:  J A Lopes; S Jorge; M Neves
Journal:  Bone Marrow Transplant       Date:  2016-02-08       Impact factor: 5.483

3.  An autopsy case that manifested no convincing histological changes of severe renal failure after hematopoietic stem cell transplantation.

Authors:  Kosuke Honda; Minoru Ando; Masaharu Tsubokura; Takuya Yamashita; Hideki Akiyama; Hisashi Sakamaki
Journal:  CEN Case Rep       Date:  2013-06-06

Review 4.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

5.  Incidence and mortality of acute kidney injury in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Authors:  S R Kanduri; W Cheungpasitporn; C Thongprayoon; T Bathini; K Kovvuru; V Garla; J Medaura; P Vaitla; K B Kashani
Journal:  QJM       Date:  2020-09-01

6.  Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation.

Authors:  Hideharu Muto; Kazuteru Ohashi; Minoru Ando; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2010-03-03       Impact factor: 2.490

7.  Hemoglobinuria in the Early Poststem-Cell-Transplant Period: Risk Factors and Association with Outcomes.

Authors:  Panagiotis Kompotiatis; Sandhya Manohar; Hassan B Alkhateeb; William J Hogan; Karl A Nath; Nelson Leung
Journal:  Kidney360       Date:  2021-08-25

8.  Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients.

Authors:  N Shingai; T Morito; Y Najima; T Kobayashi; N Doki; K Kakihana; K Ohashi; M Ando
Journal:  Bone Marrow Transplant       Date:  2015-08-24       Impact factor: 5.483

9.  Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Sarah J Kizilbash; Clifford E Kashtan; Blanche M Chavers; Qing Cao; Angela R Smith
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-29       Impact factor: 5.742

Review 10.  Clinical review: RIFLE and AKIN--time for reappraisal.

Authors:  Dinna N Cruz; Zaccaria Ricci; Claudio Ronco
Journal:  Crit Care       Date:  2009-06-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.